Here we assume that all tumour cells are equally affected by the treatment, and simulated anti-PDL1 treatment by reducing the parameter value governing the probability of a PDL1+ cancer cell suppressing a cytotoxic T cell by msupp = 0.8 after day 30 of each simulation. The gene discussed is CD274; the disease is cancer.